Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Christopher L. Case is active.

Publication


Featured researches published by Christopher L. Case.


Journal of the American College of Cardiology | 1992

Radiofrequency catheter ablation of incessant, medically resistant supraventricular tachycardia in infants and small children

Christopher L. Case; Paul C. Gillette; Paul Oslizlok; Barbara J. Knick; Henry L. Blair

OBJECTIVES This study retrospectively evaluates initial experience with radiofrequency catheter ablation in a group of seven infants and small children with a history of incessant, medically resistant supraventricular tachycardia. METHODS Before attempted catheter ablation, all patients had had unsuccessful conventional medical therapy (with digoxin or propranolol, or both) and, in addition, each continued to have daily episodes of supraventricular tachycardia while taking amiodarone or a class IC antiarrhythmic agent alone or in combination. The average patient age was 10 months (range 1 to 27) and the average patient weight was 6 kg (range 3 to 13). Electrophysiologic diagnosis included reentrant supraventricular tachycardia in six patients and atrial ectopic tachycardia in one patient. RESULTS These seven patients underwent a total of nine catheter ablation procedures. The atrial approach to ablation was employed in eight of the nine procedures. Overall, radiofrequency catheter ablation was totally successful in five of the seven patients, partially successful in one patient and unsuccessful in the remaining patient. The combination of radiofrequency catheter ablation and surgical ablation was successful in controlling tachycardia in all patients; with at least 5 months of follow-up study, no patient has had a recurrence of supraventricular tachycardia or reappearance of a delta wave. CONCLUSIONS Surgical ablation of arrhythmogenic substrates in the pediatric age group, although rarely indicated, has been found in the past to be safe and effective. Our initial experience with radiofrequency catheter ablation in infants and small children demonstrates that this procedure is a promising nonpharmacologic therapeutic alternative to surgical ablation.


American Journal of Cardiology | 1997

QRS prolongation is associated with inducible ventricular tachycardia after repair of tetralogy of Fallot

Seshadri Balaji; Yung R. Lau; Christopher L. Case; Paul C. Gillette

Prolonged QRS duration on the electrocardiogram has been found to predict adverse arrhythmic events in patients late after repair of tetralogy of Fallot. Whether QRS duration can also predict inducible ventricular tachycardia (VT) at electrophysiologic study is unknown. Between 1984 and 1995 we studied 135 survivors of tetralogy of Fallot surgery whose age at surgery was 34 days to 37 years (3.7 +/- 3.9, median 2.5) and age at electrophysiologic study was 1.4 to 43 years (9.7 +/- 8.2, median 6.7). QRS duration was 80 to 240 ms (137 +/- 29) and > or = 180 ms in 9 patients. Sustained VT was induced in 22 patients (monomorphic in 17). Induced sustained monomorphic VT was related to QRS duration, right ventricular dimension, H-V interval, and presence of symptoms. QRS duration was also related to induced sustained monomorphic VT by multivariate analysis. QRS duration > or = 180 ms was 35% sensitive and 97% specific for induced sustained monomorphic VT. QRS duration was related to induced sustained monomorphic VT even when only asymptomatic patients were analyzed. A QRS duration > or = 180 ms was 100% sensitive and 96% specific for detecting clinical VT. Prolonged QRS duration on the electrocardiogram is associated with induced sustained monomorphic VT on electrophysiologic study. The finding of prolonged QRS duration should suggest the need for further testing to determine the risk of adverse arrhythmic events in patients after repair of tetralogy of Fallot, even if they are asymptomatic.


Journal of the American College of Cardiology | 1996

Radiofrequency catheter ablation of right ventricular outflow tachycardia in children and adolescents

Brian K. O'Connor; Christopher L. Case; Mary C. Sokoloski; Henry L. Blair; Kathe Cooper; Paul C. Gillette

OBJECTIVES The current study reviews the safety and efficacy of radiofrequency catheter ablation for the treatment of right ventricular outflow tachycardia in children and adolescents and describes a modified method for mapping the tachycardia focus. BACKGROUND Although radiofrequency catheter ablation has proved highly effective for the treatment of supraventricular tachycardia during childhood and adolescence, its application in children with idiopathic right ventricular outflow tachycardia has been limited. METHODS Six children (mean [+/- SD] age 10.6 +/- 2.4 years, range 6 to 16) with right ventricular outflow tachycardia underwent seven radiofrequency catheter ablation procedures. The mean tachycardia cycle length was 323 +/- 24 ms (range 300 to 360). Two multipolar catheters were positioned in the right ventricular outflow tract to map the tachycardia focus. RESULTS Radiofrequency catheter ablation was successful in five (83%) of the six children (95% confidence interval 36% to 99%). At successful ablation sites, local endocardial activation time preceded the surface QRS onset by 46 +/- 5 ms (range 37 to 57), and there was concordance of the 12-lead pace map and the electrocardiogram (ECG) in 11 (one patient) to 12 ECG leads (four patients). One patient developed complete right bundle branch block during radiofrequency catheter ablation. There were no additional complications and no clinical recurrences over a mean follow-up period of 12.7 +/- 3.8 months (range 9 to 22). CONCLUSIONS These results suggest that radiofrequency catheter ablation is a safe and effective treatment for right ventricular outflow tachycardia during childhood and adolescence. In addition, tachycardia mapping may be enhanced by use of a multipolar right ventricular outflow catheter technique.


Pacing and Clinical Electrophysiology | 1991

Transvenous Cryoablation of the Bundle of His

Paul C. Gillette; Robert P. Thompson; Christopher L. Case

Cardiac dysrhythmias are a prominent cause of morbidity and mortality. Pharmacological treatment is ineffective in a large number of patients and is associated with many serious side effects. Thus, direct treatment of cardiac arrhythmias has been used with increasing frequency. Each form of direct treatment, such as surgical ablation, DC catheter ablation, radiofrequency catheter ablation, laser catheter ablation suffer serious drawbacks. Thus, we investigated the utility of transvenous catheter cryoablation of the bundle of His in five miniature swine, 40–60 lbs. in weight. Complete atrioventricular block was produced in each animal during cryothermia and persisted for 1 hour of observation in four out of five swine. In the fifth animal, 2:1 atrioventricular block within the atrioventricular node persisted for 1 hour of observation. Morphological and histologic examination revealed no dysfunction of capillaries and myofibriles in the atrioventricular node and proximal bundle of His. This potential mode of transcatheter therapy deserves further investigation.


Journal of the American College of Cardiology | 1995

Pulmonary/systemic flow ratio in children after cavopulmonary anastomosis

Mubadda A. Salim; Christopher L. Case; Robert M. Sade; Donald C. Watson; Bruce S. Alpert; Thomas G. DiSessa

OBJECTIVES This study attempted to provide a formula for calculation of the pulmonary/systemic flow ratio in children after bidirectional cavopulmonary anastomosis. BACKGROUND With the bidirectional cavopulmonary anastomosis, only the superior vena cava blood is oxygenated by the lungs. The inferior vena cava flow recirculates into the systemic circulation. The ratio of these flows will determine systemic arterial saturation. METHODS According to the Fick principle, 1) Systemic cardiac output (liters/min) = Pulmonary venous flow + Inferior vena cava flow; 2) Systemic blood oxygen transport (ml/min) = Pulmonary venous blood oxygen transport + Inferior vena cava blood oxygen transport. By substituting the first equation into the second, Pulmonary/systemic flow ratio = (Systemic saturation - Inferior vena cava saturation)/(Pulmonary venous saturation - Inferior vena cava saturation). RESULTS We applied the third formula to data obtained from 34 catheterizations in 29 patients after bidirectional cavopulmonary anastomosis. Mean [+/- SD] age at operation was 1.70 +/- 1.43 years, and mean age at catheterization was 2.95 +/- 1.65 years. The pulmonary/systemic flow ratio calculated for all 29 patients was 0.58 +/- 0.09. Of 17 patients with aortography, 10 had systemic to pulmonary collateral vessels. Patients with collateral vessels had a significantly higher pulmonary/systemic flow ratio (0.61 +/- 0.07 vs. 0.53 +/- 0.07, respectively, p < 0.02) and systemic saturation (88 +/- 4% vs. 82 +/- 4%, respectively, p < 0.002) than those without collateral vessels. The pulmonary/systemic flow ratio in those patients with no collateral vessels was similar to the previously reported echocardiographically derived superior vena cava/systemic flow ratio in normal children. CONCLUSIONS The pulmonary/systemic flow ratio after bidirectional cavopulmonary anastomosis can be calculated. Pulmonary blood flow in these patients determines systemic saturation and accounts for the majority of venous return in young children.


Pacing and Clinical Electrophysiology | 1993

Automatic Atrial and Junctional Tachycardias in the Pediatric Patient: Strategies for Diagnosis and Management

Christopher L. Case; Paul C. Gillette

Unlike supraventricular arrhythmias secondary to reentry, automatic rhylhm disturbances in children are rare and more resislant to standard pharmacological therapy. This article reviews strategies for the diagnosis and managemenl of two of the more common pediatric auto‐matic rhylhm disliirbances, that is, atrial ectopic tachycardia, and junlional ectopic tachycardia. The place of nevver nonpharmacological therapy, such as catheter ablation, in the treatment of these entities is beginning to be explored, yet has not been fully delineated. Despite these iimitalions, there is enough experience ivith these difficult tachycardias in the pediatric age group to formulate some strategies for optimal diagnosis and management.


The Journal of Pediatrics | 1993

Prospective study of the electrocardiographic effects of imipramine in children

Scott E. Fletcher; Christopher L. Case; Floyd R. Sallee; Lisa D. Hand; Paul C. Gillette

Because imipramine and desipramine have been implicated in sudden death in children, noninvasive electrophysiologic data were accumulated in 25 patients. Two children were excluded on the basis of resting electrocardiographic and Holter abnormalities. The remaining 23 patients received imipramine to a maximum dose of 5 mg/kg or a serum level of 150 to 250 ng/ml. Consistent but clinically insignificant resting electrocardiographic changes occurred during treatment. Ambulatory electrocardiographic monitoring may be useful when one is assessing the cardiovascular risks of imipramine therapy.


American Journal of Obstetrics and Gynecology | 1991

Myocardial necrosis in a newborn after long-term maternal subcutaneous terbutaline infusion for suppression of preterm labor

Scott E. Fletcher; Derek A. Fyfe; Christopher L. Case; Henry B. Wiles; Jane K. Upshur; Roger B. Newman

We report a case of myocardial necrosis in a newborn after treatment of the mother with long-term subcutaneous terbutaline. No such serious side effects in the fetus have previously been reported. We speculate that this myocardial damage was due to beta-sympathomimetic therapy.


Pacing and Clinical Electrophysiology | 1994

Radiofrequency catheter ablation of atrioventricular nodal reentrant tachycardia in children.

Otto H.P. Teixeira; Seshadri Balaji; Christopher L. Case; Paul C. Gillette

Radiofrequency (RF) catheter ablation has been widely used in the treatment of cardiac arrhythmias. In atrioventricular nodal reentrant tachycardia (AVNRT), the experience has been predominantly in adults. The cardiac electrophysiological records of 18 consecutive children undergoing RF catheter AV node modification for AVNRT were reviewed. The patients (10 females, 8 males) were 8.2–17.9 years of age (mean 13.6 ± 3.0), weight 15.2–88.1 kg (mean 52.2 ± 20.8), and height 103–190 cm (mean 157.1 ± 21.7). Thirteen were on antiarrhythmic medications (1–3, average 1.5 drugs/day). All drugs were discontinued 48 hours prior to the ablations. The procedures were performed under sedation and local anesthesia. Pre‐ and post‐AV node modification electrophysiological studies were performed in all procedures. The 18 patients underwent a total of 25 procedures (1.39 ± 0.61 per patient): the anterior approach aimed at the antegrade fast pathway in the first four patients and the posterior approach aimed at the slow pathway in the remainder. Thenumber of energy applications was 8–54 (19.8 ± 10.7) per procedure. The maximum energy used in each procedure was 30–50 watts (33.8 ± 8.4). The average energy was 24–50 watts (33.0 ± 6.8). The fluoroscopy time was 7.1–73.4 minutes (29.9 ± 20.0) per procedure, for a total catheterization time of 228–480 minutes (300.3 ± 59.1). Preablation spontaneous or induced AVNRT (cycle length 310.4 ± 55.0 msec) was seen in all except one who had the arrhythmia (cycle length 270 msec) on surface ECG. In 22 of 25 studies, the AH interval measured 67.4 ± 13.2 msec pre‐ and 98.7 ± 58.4 msec post‐AV node modification (P < 0.02). Procedures were initially successful in 16 (89%) of 18 patients. One patient developed complete AV block requiring DDD pacemaker and has since recovered normal AV conduction. Transient third‐ or second‐degree block was seen in four. Other complications included airway obstruction in one and excessive emesis in another. In follow‐up of 2–26 months (13.0 ± 7.3), one patient underwent surgical ablation for failed initial RF catheter ablation, and two underwent successful RF procedures for recurrences. RF catheter AV node modification for AVNRT in children is a useful technique. Under ideal circumstances, it is safe and efficacious. Follow‐up to determine the potential long‐term complications is necessary.


American Journal of Cardiology | 1991

Clinical spectrum of venous thrombi in the Fontan patient

Scott E. Fletcher; Christopher L. Case; Derek A. Fyfe; Paul C. Gillette

Abstract Venous thrombus formation is a known complication after the Fontan procedure. To characterize the clinical presentation, diagnostic methods, treatment regimens and outcome of this disease process, we retrospectively reviewed the records of 7 patients who developed systemic venous or pulmonary arterial thrombosis after modifications of the Fontan operation. Clinical features were analyzed to identify “risk factors” that may predispose to thrombus formation.

Collaboration


Dive into the Christopher L. Case's collaboration.

Top Co-Authors

Avatar

Paul C. Gillette

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

Kenneth W. Hewett

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

Vicki L. Zeigler

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

Fred A. Crawford

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

Seshadri Balaji

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

Barbara J. Knick

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

Paul Oslizlok

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

Brian K. O'Connor

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

Christine A. McKay

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

David S. Buckles

Medical University of South Carolina

View shared research outputs
Researchain Logo
Decentralizing Knowledge